Deborah J Andrews

Chief Financial Officer & EVP; Director; Interim Co-CEO and CFO · 5 filings · Latest: Jul 1, 2026

Lineage Cell Therapeutics, Inc.

STAAR SURGICAL CO

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
STAA	Deborah J Andrews	Chief Financial Officer & EVP	Jul 31, 2026	Option Exercise	—	20,787	—	46,915	Aug 4 8:30 PM
STAA	Deborah J Andrews	Chief Financial Officer & EVP	Jun 25, 2026	Option Exercise	—	13,955	—	32,608	Aug 4 8:30 PM